Health Catalyst, Inc. (HCAT)
1.51
+0.15
(+11.03%)
USD |
NASDAQ |
Nov 13, 16:00
1.50
-0.01
(-0.66%)
After-Hours: 19:59
Health Catalyst Enterprise Value : 51.76M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 51.76M |
| November 12, 2026 | 40.33M |
| November 11, 2026 | 45.66M |
| November 10, 2026 | 46.43M |
| November 09, 2026 | 51.76M |
| November 06, 2026 | 47.95M |
| November 05, 2026 | 51.00M |
| November 04, 2026 | 57.85M |
| November 03, 2026 | 46.43M |
| November 02, 2026 | 57.09M |
| October 30, 2026 | 65.46M |
| October 29, 2026 | 73.08M |
| October 28, 2026 | 73.84M |
| October 27, 2026 | 56.33M |
| October 26, 2026 | 60.90M |
| October 23, 2026 | 65.46M |
| October 22, 2026 | 69.27M |
| October 21, 2026 | 69.27M |
| October 20, 2026 | 70.03M |
| October 19, 2026 | 66.99M |
| October 16, 2026 | 68.13M |
| October 15, 2026 | 73.84M |
| October 14, 2026 | 69.27M |
| October 13, 2026 | 69.27M |
| October 12, 2026 | 70.03M |
| Date | Value |
|---|---|
| October 09, 2026 | 71.56M |
| October 08, 2026 | 70.03M |
| October 07, 2026 | 70.80M |
| October 06, 2026 | 71.56M |
| October 05, 2026 | 70.80M |
| October 02, 2026 | 70.03M |
| October 01, 2026 | 66.23M |
| September 30, 2026 | 68.51M |
| September 29, 2026 | 197.09M |
| September 28, 2026 | 198.58M |
| September 25, 2026 | 196.34M |
| September 24, 2026 | 196.34M |
| September 23, 2026 | 194.85M |
| September 22, 2026 | 207.53M |
| September 21, 2026 | 201.56M |
| September 18, 2026 | 200.07M |
| September 17, 2026 | 200.82M |
| September 16, 2026 | 195.59M |
| September 15, 2026 | 194.85M |
| September 14, 2026 | 202.31M |
| September 11, 2026 | 193.36M |
| September 10, 2026 | 195.59M |
| September 09, 2026 | 195.59M |
| September 08, 2026 | 193.36M |
| September 04, 2026 | 192.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 7.107M |
| SCWorx Corp. | -1.154M |
| GoodRx Holdings, Inc. | 1.454B |
| Claritev Corp. | 5.171B |
| iSpecimen, Inc. | -3.171M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 40.50M |
| Revenue (Quarterly) | 56.28M |
| Total Expenses (Quarterly) | 15.79M |
| EPS Diluted (Quarterly) | 0.5333 |
| Gross Profit Margin (Quarterly) | 25.67% |
| Profit Margin (Quarterly) | 71.95% |
| Earnings Yield | -187.2% |
| Normalized Earnings Yield | -44.41 |